home / stock / btaff / btaff quote
Last: | $28.778 |
---|---|
Change Percent: | -4.74% |
Open: | $30.34 |
Close: | $28.778 |
High: | $30.39 |
Low: | $28.778 |
Volume: | 1,105 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$28.778 | $30.34 | $28.778 | $30.39 | $28.778 | 1,105 | 04-26-2024 |
$28.968 | $29.182 | $28.968 | $29.28 | $28.968 | 5,927 | 04-25-2024 |
$28.85 | $28.85 | $28.85 | $28.85 | $28.85 | 555 | 04-24-2024 |
$29.19 | $29.31 | $29.19 | $30.54 | $29.19 | 1,422 | 04-23-2024 |
$30.26 | $28.838 | $30.26 | $30.26 | $28.838 | 2,131 | 04-22-2024 |
$28 | $28.23 | $28 | $29.11 | $28 | 1,306 | 04-19-2024 |
$29.44 | $28.25 | $29.44 | $29.44 | $28.25 | 5,683 | 04-18-2024 |
$28.176 | $28.308 | $28.176 | $28.7 | $28.176 | 1,761 | 04-17-2024 |
$28.01 | $28.736 | $28.01 | $29.048 | $28.01 | 2,044 | 04-16-2024 |
$29.2187 | $29.06 | $29.2187 | $29.2187 | $28.25 | 1,764 | 04-15-2024 |
$28.456 | $29 | $28.456 | $29.01 | $28.456 | 5,147 | 04-12-2024 |
$28.766 | $28.93 | $28.766 | $28.93 | $28.766 | 1,591 | 04-11-2024 |
$28.856 | $28.856 | $28.856 | $28.856 | $28.856 | 2,797 | 04-10-2024 |
$29.136 | $29.394 | $29.136 | $29.84 | $29.136 | 2,855 | 04-09-2024 |
$30.43 | $30.412 | $30.43 | $30.44 | $29.25 | 1,645 | 04-08-2024 |
$28.919 | $30.428 | $28.919 | $30.428 | $28.919 | 2,778 | 04-05-2024 |
$30 | $30.438 | $30 | $30.45 | $30 | 1,970 | 04-04-2024 |
$29.964 | $30.488 | $29.964 | $30.488 | $29.964 | 1,391 | 04-03-2024 |
$30 | $30 | $30 | $30 | $30 | 550 | 04-02-2024 |
$30.2 | $30.6 | $30.2 | $30.6 | $29.4 | 3,593 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
British American Tobacco Plc Company Name:
BTAFF Stock Symbol:
OTCMKTS Market:
The FDA has reportedly ordered Reynolds American to stop selling menthol-flavored versions of its Vuse Alto e-cigarette. Reynolds America...
LONDON , Sept. 12, 2019 /PRNewswire/ -- Kingsley Wheaton , Chief Marketing Officer, British American Tobacco, said: "We welcome the USA's Food & Drug Administration (FDA) shining a spotlight on the important issue of preventing youth access to vapour products and consu...